Koers CaliPharms, Inc. Other OTC
Aandelen
KGET
US4984561021
Farmaceutische producten
Omzet 2012 | - | Omzet 2013 | - | Marktkapitalisatie | 8,23 mln. 7,57 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | - 0 | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 * | - |
Nettoschuld 2012 | 617K 567K | Nettoschuld 2013 | 667K 613K | EV/omzet 2013 | - |
K/w-verhouding 2012 * |
-
| K/w-verhouding 2013 |
-0,51
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,38% | 6,26 mld. | |
-15,86% | 4,49 mld. | |
+6,36% | 3,29 mld. | |
-11,28% | 3,12 mld. | |
-3,23% | 2,5 mld. | |
+45,24% | 1,94 mld. | |
-7,89% | 1,68 mld. | |
-0,98% | 1,63 mld. | |
-11,32% | 1,56 mld. |